Table 4.
Predictors of rehospitalization due to HF across etiology categories-results of separate COX analysis.
| ICM |
NICM |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | Univariable |
P | Multivariable |
P | Variables | Univariable |
P | Multivariable |
P |
| HR (95%CI) | HR (95%CI) | HR (95%CI) | HR (95%CI) | ||||||
| Previous HF hospitalization | 1.561 (1.105–2.207) | 0.012 | 1.477 (1.032–2.114) | 0.033 | SBP (mmHg) | 0.992 (0.984–1.000) | 0.047 | ||
| Af/AFL | Previous HF hospitalization | 1.747 (1.200–2.545) | 0.004 | 1.484 (1.000–2.202) | 0.050 | ||||
| paroxysmal | 1.953 (1.046–3.644) | 0.036 | Af/AFL | ||||||
| persistent | 1.581 (1.003–2.492) | 0.048 | paroxysmal | 1.894 (1.030–3.481) | 0.040 | 1.956 (1.023–3.739) | 0.042 | ||
| Frequent PVB | 1.670 (1.143–2.442) | 0.008 | 1.618 (1.098–2.384) | 0.015 | persistent | 1.065 (0.718–1.580) | 0.755 | ||
| Diabetes mellitus | 1.611 (1.136–2.284) | 0.007 | 1.615 (1.128–2.314) | 0.009 | Frequent PVB | 1.550 (1.071–2.245) | 0.020 | ||
| LVEF | 0.983 (0.962–1.005) | 0.126 | Non-sustained VT | 1.648 (1.152–2.357) | 0.006 | ||||
| eGFR | 0.986 (0.980–0.992) | <0.0001 | 0.989 (0.983–0.996) | 0.001 | LVEF | 0.971 (0.948–0.994) | 0.015 | 0.973 (0.947–0.999) | 0.040 |
| Low T3 syndrome | 2.450 (1.369–4.384) | 0.003 | 2.051 (1.125–3.740) | 0.019 | LBBB | 1.563 (1.015–2.406) | 0.043 | ||
| Digoxin | 1.526 (1.039–2.242) | 0.031 | eGFR | 0.991 (0.985–0.997) | 0.004 | ||||
| Aspirin | 0.660 (0.439–0.993) | 0.046 | Na+ (mmol/l) | 0.951 (0.912–0.990) | 0.016 | ||||
| Statin | 0.446(0.270–0.734) | 0.002 | ACEI/ARB | 0.598 (0.386–0.927) | 0.021 | ||||
| Isosorbide mononitrate | 1.517 (1.012–2.275) | 0.044 | |||||||
| QRS duration (ms) | 1.007 (1.002–1.013) | 0.006 | |||||||